Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Core Insights - Eledon Pharmaceuticals will participate in the Leerink Partners Global Healthcare Conference on March 11, 2025, with a fireside chat featuring Chief Scientific Officer Steve Perrin, Ph.D. [1] - The company is focused on developing immune-modulating therapies for life-threatening conditions, with its lead product being tegoprubart, an anti-CD40L antibody [3] Company Overview - Eledon Pharmaceuticals is a clinical stage biotechnology company headquartered in Irvine, California [3] - The company is developing therapies targeting CD40 Ligand, which has significant therapeutic potential in various conditions [3] - Eledon is conducting preclinical and clinical studies in areas such as kidney allograft transplantation, xenotransplantation, and amyotrophic lateral sclerosis (ALS) [3]